
How an Indian Government Policy Backfired: Prescription Drug Price Regulations Led to More Marketing for Unregulated Medications
A new Journal of Marketing study shows how India aimed to make essential medicines more affordable but inadvertently ended up reducing drug sales.
Read an in-depth recap of this research here: https://www.ama.org/2024/06/04/how-an-indian-government-policy-backfired-prescription-drug-price-regulations-led-to-more-marketing-for-unregulated-medications/
Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429241242685
Reference: Saravana Jaikumar, Pradeep K. Chintagunta, and Arvind Sahay, “Do No Harm? Unintended Consequences of Pharmaceutical Price Regulation in India,” Journal of Marketing.
Narrator: Adalgisa Butkewitsch
Acknowledgments: Sushma Kambagowni
Topics: regulations, drug prices, healthcare marketing
The JM Buzz Podcast is a production of the American Marketing Association's Journal of Marketing and is produced by University FM
Otros episodios de "The JM Buzz"
No te pierdas ningún episodio de “The JM Buzz”. Síguelo en la aplicación gratuita de GetPodcast.